You got your vitamin D result back, and it's a number with a unit you may not recognize and a reference range that might not match what you read online. Here's how to make sense of it, and why the experts don't all agree.
Written by Vita Globe Editorial Team | Reviewed against NIH guidance, the Institute of Medicine, Endocrine Society guidelines and USPSTF
What is a normal vitamin D level?
The NIH considers a 25-hydroxyvitamin D level of 20 ng/mL (50 nmol/L) or higher adequate for most people. Below 12 ng/mL (30 nmol/L) is deficient, and above 50 ng/mL (125 nmol/L) is linked to potential adverse effects[1][2]. Some labs use 30 ng/mL as the low cutoff, based on older Endocrine Society guidance[3]. The 2024 Endocrine Society guideline doesn't endorse any target and advises against routine testing in healthy adults[4].
Caveat: Different cutoffs reflect genuine scientific disagreement, not a lab mistake. Interpret your result with your doctor in the context of your health.
Sources: NIH ODS · Endocrine Society 2011 · Endocrine Society 2024 · Verified 2026-09-27
IN THIS ARTICLE
What does a vitamin D blood test measure?
The standard test measures 25-hydroxyvitamin D, often written as 25(OH)D. It's the main circulating form of vitamin D and reflects what you get from sun, food and supplements. It's considered the best indicator of vitamin D status[1].
It's not the same as the "active" vitamin D test (1,25-dihydroxyvitamin D), which is used for specific medical questions and isn't a good measure of whether you're getting enough[1].
ng/mL vs. nmol/L: how do you convert?
U.S. labs usually report ng/mL, while many other countries use nmol/L. The conversion is simple: 1 ng/mL equals 2.5 nmol/L, and 1 nmol/L equals 0.4 ng/mL[1].
| ng/mL | nmol/L | NIH interpretation |
|---|---|---|
| Below 12 | Below 30 | Deficient |
| 12 to under 20 | 30 to under 50 | Generally considered inadequate for bone and overall health |
| 20 to 50 | 50 to 125 | Adequate for most people |
| Above 50 | Above 125 | Linked to potential adverse effects |
These NIH ranges draw on the 2011 Institute of Medicine report, which concluded that 20 ng/mL meets the needs of nearly everyone in the population for bone health[1][2].
Why do experts disagree about the cutoffs?
You may see 30 ng/mL described as the minimum. That comes from the Endocrine Society's 2011 guideline, which defined deficiency as below 20 ng/mL and insufficiency as 21 to 29 ng/mL, and aimed for levels above 30 ng/mL[3]. Many lab reports still use this range.
The Endocrine Society's 2024 guideline changed course. After reviewing the trial evidence, the panel found no clear evidence for a specific 25(OH)D level that prevents disease, so it didn't endorse any threshold. It also suggested against routine testing in the general population, including people with darker skin or obesity[4].
The U.S. Preventive Services Task Force reached a similar place, concluding the evidence is insufficient to recommend for or against screening adults who have no symptoms[5].
The honest summary
- 20 ng/mL (50 nmol/L) or higher is adequate for most people, per the NIH[1].
- 30 ng/mL is an older target from 2011 that many labs still use[3].
- Current guidance doesn't support routine testing for healthy adults[4][5].
What if your level is high?
Levels above 50 ng/mL (125 nmol/L) are linked to potential adverse effects[1]. True toxicity from overdosing usually involves levels above 150 ng/mL (375 nmol/L)[6]. A high reading usually means it's time to review every source of vitamin D you're taking. We cover this in Can you take too much vitamin D?.
Who should get tested?
Testing makes more sense when there's a clinical reason, such as symptoms or conditions that suggest deficiency, malabsorption disorders like celiac or Crohn's disease, kidney or liver disease, osteoporosis, or long-term use of medications that affect vitamin D. The 2011 Endocrine Society guideline recommended testing for people at risk of deficiency like these, rather than for everyone[3]. We list those medications in vitamin D and medications, and the signs of low vitamin D in vitamin D deficiency signs, causes and treatment.
If you're treated for a deficiency, your doctor may recheck your level later on, since blood levels take weeks to respond to a new dose[1]. For typical daily doses, see How much vitamin D3 per day?.
Our option
Vita Globe Vitamin D3 2,000 IU Gummies
Each 2-gummy serving provides 2,000 IU (50 mcg) of vitamin D3 in a strawberry-flavored gummy that's vegan, gluten-free and non-GMO, and tested by an independent third-party lab. A steady daily dose at half the adult upper limit. If your test shows a deficiency, follow your doctor's plan, which may call for a different dose.
Frequently asked questions
What is a good vitamin D level in ng/mL?
The NIH considers 20 ng/mL (50 nmol/L) or higher adequate for most people[1]. Some labs use 30 ng/mL as the minimum, based on the 2011 Endocrine Society guideline[3].
How do I convert nmol/L to ng/mL?
Divide nmol/L by 2.5, or multiply by 0.4. For example, 75 nmol/L equals 30 ng/mL[1].
Is 30 ng/mL of vitamin D low?
By NIH ranges, no. It's adequate[1]. By the older 2011 Endocrine Society definition, it's at the bottom of the sufficient range[3].
Should I get my vitamin D tested?
Not routinely if you're healthy. The 2024 Endocrine Society guideline and USPSTF don't support routine screening in adults without symptoms[4][5]. Your doctor may test if there's a reason.
What vitamin D level is too high?
Above 50 ng/mL (125 nmol/L) is linked to potential adverse effects[1]. Toxicity usually involves levels over 150 ng/mL[6].
Sources
- Office of Dietary Supplements, National Institutes of Health. Vitamin D: Fact Sheet for Health Professionals. Accessed September 27, 2026. ods.od.nih.gov/factsheets/VitaminD-HealthProfessional
- Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58. doi:10.1210/jc.2010-2704
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. doi:10.1210/jc.2011-0385
- Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. doi:10.1210/clinem/dgae290
- US Preventive Services Task Force; Krist AH, Davidson KW, et al. Screening for vitamin D deficiency in adults: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(14):1436-1442. doi:10.1001/jama.2021.3069
- Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, et al. Vitamin D toxicity: a clinical perspective. Front Endocrinol. 2018;9:550. doi:10.3389/fendo.2018.00550
About the Vita Globe Editorial Team
The Vita Globe Editorial Team researches and writes our wellness content, working from peer-reviewed research, systematic reviews and guidance from bodies such as the NIH and the FDA. We cite our sources inline and update articles when the evidence changes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for medical advice. Talk to your healthcare provider before starting any new supplement, particularly if you are pregnant, nursing, taking medication, or caring for a child.
